APA (7th ed.) Citation

M, G., MÁ, B., E, M., JL, M., P, C., G, C., . . . I, M. (2026). Poor efficacy of anti PD-1 antibody based immunotherapy in patients with acral melanoma: Results from the Spanish Melanoma Group (GEM) registry. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 28(2), 645. https://doi.org/10.1007/s12094-025-04018-5

Chicago Style (17th ed.) Citation

M, Gonzalez-Cao, et al. "Poor Efficacy of Anti PD-1 Antibody Based Immunotherapy in Patients with Acral Melanoma: Results from the Spanish Melanoma Group (GEM) Registry." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 28, no. 2 (2026): 645. https://doi.org/10.1007/s12094-025-04018-5.

MLA (9th ed.) Citation

M, Gonzalez-Cao, et al. "Poor Efficacy of Anti PD-1 Antibody Based Immunotherapy in Patients with Acral Melanoma: Results from the Spanish Melanoma Group (GEM) Registry." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 28, no. 2, 2026, p. 645, https://doi.org/10.1007/s12094-025-04018-5.